WEST PHARMACEUTICAL SERVICES, INC. Share-based Compensation Arrangements by Share-based Payment Award, Options, Exercises in Period, Weighted Average Exercise Price
WEST PHARMACEUTICAL SERVICES, INC. (WST) reported Share-based Compensation Arrangements by Share-based Payment Award, Options, Exercises in Period, Weighted Average Exercise Price of $75.54 per share for the 12-month period ending 2025-12-31, per its 10-K filed 2026-02-17.
Financial Statements › Notes › Compensation Related Costs › Share-Based Payment Arrangement, Disclosure
us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice · last filed 2026-02-17
- WEST PHARMACEUTICAL SERVICES, INC. share-based compensation arrangements by share-based payment award, options, exercises in period, weighted average exercise price for fiscal 2025 was $75.54, a 3.00% decline from fiscal 2024.
- WEST PHARMACEUTICAL SERVICES, INC. share-based compensation arrangements by share-based payment award, options, exercises in period, weighted average exercise price for fiscal 2024 was $77.88, a 2.87% decline from fiscal 2023.
- WEST PHARMACEUTICAL SERVICES, INC. share-based compensation arrangements by share-based payment award, options, exercises in period, weighted average exercise price for fiscal 2023 was $80.18, a 4.29% decline from fiscal 2022.
- WEST PHARMACEUTICAL SERVICES, INC. share-based compensation arrangements by share-based payment award, options, exercises in period, weighted average exercise price for fiscal 2022 was $83.77, a 38.17% increase from fiscal 2021.
| Period end | Share-based Compensation Arrangements by Share-based Payment Award, Options, Exercises in Period, Weighted Average Exercise Price 12 month | Share-based Compensation Arrangements by Share-based Payment Award, Options, Exercises in Period, Weighted Average Exercise Price 12 month as first filed |
|---|---|---|
| 2025-12-31 | $75.54 10-K · filed 2026-02-17 | |
| 2024-12-31 | $77.88 10-K · filed 2025-02-18 | |
| 2023-12-31 | $80.18 10-K · filed 2024-02-20 | |
| 2022-12-31 | $83.77 10-K · filed 2023-02-21 | |
| 2021-12-31 | $60.63 10-K · filed 2022-02-22 | |
| 2020-12-31 | $49.99 10-K · filed 2022-02-22 | |
| 2019-12-31 | $46.42 10-K · filed 2022-02-22 | |
| 2018-12-31 | $35.95 10-K · filed 2021-02-23 | |
| 2017-12-31 | $26.15 10-K · filed 2020-02-24 | |
| 2016-12-31 | $22.50 10-K · filed 2019-02-28 | |
| 2015-12-31 | $21.85 10-K · filed 2018-02-26 | |
| 2014-12-31 | $20.17 10-K · filed 2017-02-28 | |
| 2013-12-31 | $18.97 10-K · filed 2016-02-26 | |
| 2012-12-31 | $13.12 10-K · filed 2015-02-25 | $26.23 10-K · filed 2013-02-27 |
| 2011-12-31 | $8.84 10-K · filed 2014-02-27 | $17.69 10-K · filed 2013-02-27 |
| 2010-12-31 | $14.88 10-K · filed 2013-02-27 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| DEXCOM INC (DXCM) | United States | $33.004B | 25.42 |
| Solventum Corp (SOLV) | United States | $15.085B | 9.16 |
| Penumbra Inc (PEN) | United States | $12.596B | 77.33 |
| BAXTER INTERNATIONAL INC (BAX) | United States | $12.139B | -10.35 |
| GLOBUS MEDICAL INC (GMED) | United States | $9.977B | 20.03 |
| INSULET CORP (PODD) | United States | $9.420B | 28.12 |
| GLAUKOS Corp (GKOS) | United States | $9.135B | -43.73 |
| MiniMed Group, Inc. (MMED) | United States | $5.748B | -16.85 |
| MERIT MEDICAL SYSTEMS INC (MMSI) | United States | $5.212B | 28.44 |
| TELEFLEX INC (TFX) | United States | $5.093B | -5.44 |